Heartstitch GmbH
About Heartstitch GmbH
HeartStitch® Inc. was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the structural heart marketplace. HeartStitch® is focused on innovative suture-based systems for remotely providing suture repair of structural heart defects and other vascular structures.YEAR FOUNDED:
December 2009
LEADERSHIP:
Founder and CEO: Anthony Nobles
CFO: Richard Bjorkman
7 articles about Heartstitch GmbH
-
HeartStitch® Appoints Benjamin S. Carson Sr. To Its Board Of Directors
5/3/2021
HeartStitch® has announced the appointment of a renowned Neurosurgeon and former Secretary of the US Department of Housing and Urban Development to its Board of Directors.
-
HeartStitch® Presents Initial Clinical Results Of New Tricuspid Valve Repair At CSI Frankfurt Clinical Congresses
7/24/2018
HeartStitch® Presented Initial Data For Its New Suture-based tricuspid valve repair and remodeling technique.
-
HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair
4/18/2018
HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair.
-
HeartStitch® Inc. has received CE Mark for Its Suture Based Trans-Apical Access and Closure
4/12/2018
HeartStitch®, Inc. Announces CE Mark for its Minimally Invasive Trans-Apical Access and Closure Device
-
Revolutionary New Heart Valve Repair -- Performed for The First Time In Patients -- Demonstrates Feasibility of New Suture Based Technique
4/10/2018
HeartStitch®, Inc. And National Research Cardiac Surgery Center in Astana Announce Successful Clinical Test of Novel Tricuspid Valve Repair With Minimally Invasive HeartStitch® Suture Technique On Two Patients.
-
HeartStitch Leading the Growth of PFO Closure in Italy
12/12/2017
Kardia announced expansion plan of the NobleStitch EL at a recent meeting organized by Professor Francesco Romeo at Policlinico Tor Vergata in Rome where Prof. Achille Gaspardone performed a successful NobleStitch™ EL live case that was transmitted to the attendees in Ayla Magna, Rome, Italy.
-
Heartstitch GmbH Announces Noblestitch EL Closure Data Compared To Published PFO Clinical Trials "RESPECT" And "CLOSURE" In The New England Journal of Medicine
10/10/2017